nodes	percent_of_prediction	percent_of_DWPC	metapath
Conivaptan—AVPR2—urine—polycystic ovary syndrome	0.147	0.549	CbGeAlD
Conivaptan—AVPR1A—adrenal gland—polycystic ovary syndrome	0.0339	0.127	CbGeAlD
Conivaptan—AVPR2—adipose tissue—polycystic ovary syndrome	0.0313	0.117	CbGeAlD
Conivaptan—AVPR1A—endocrine gland—polycystic ovary syndrome	0.0294	0.11	CbGeAlD
Conivaptan—CYP3A4—urine—polycystic ovary syndrome	0.0224	0.0836	CbGeAlD
Conivaptan—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00371	0.0139	CbGeAlD
Conivaptan—AVPR1A—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.00173	0.00237	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.00173	0.00237	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.00173	0.00237	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.00172	0.00235	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.00172	0.00235	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.00172	0.00235	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.00169	0.0023	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.00167	0.00228	CbGpPWpGaD
Conivaptan—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—polycystic ovary syndrome	0.00163	0.00222	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.00162	0.00221	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.00161	0.0022	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.00157	0.00215	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.00156	0.00213	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.00154	0.00211	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.00153	0.00209	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.00153	0.00209	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.00153	0.00209	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.00152	0.00208	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.00152	0.00207	CbGpPWpGaD
Conivaptan—CYP3A4—Estrogen metabolism—CYP1A1—polycystic ovary syndrome	0.00148	0.00202	CbGpPWpGaD
Conivaptan—AVPR1A—Peptide ligand-binding receptors—POMC—polycystic ovary syndrome	0.00144	0.00196	CbGpPWpGaD
Conivaptan—AVPR2—Peptide ligand-binding receptors—POMC—polycystic ovary syndrome	0.00143	0.00195	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.00142	0.00194	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.00141	0.00192	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—FLT4—polycystic ovary syndrome	0.0014	0.00192	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.0014	0.00191	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—FLT4—polycystic ovary syndrome	0.00139	0.0019	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.00139	0.0019	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.00139	0.00189	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.00138	0.00189	CbGpPWpGaD
Conivaptan—CYP3A4—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.00136	0.00186	CbGpPWpGaD
Conivaptan—CYP3A4—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.00131	0.00178	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.00128	0.00174	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.00127	0.00173	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.00127	0.00173	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.00126	0.00172	CbGpPWpGaD
Conivaptan—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—polycystic ovary syndrome	0.00126	0.00171	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.00123	0.00168	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NPB—polycystic ovary syndrome	0.00123	0.00167	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.00122	0.00167	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NPB—polycystic ovary syndrome	0.00122	0.00166	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.00122	0.00166	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.00121	0.00165	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.00119	0.00162	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.00118	0.00161	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.00118	0.0016	CbGpPWpGaD
Conivaptan—AVPR2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.00117	0.0016	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.00117	0.00159	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.00116	0.00158	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.00115	0.00157	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.00114	0.00155	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.00113	0.00154	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.00112	0.00152	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.00111	0.00151	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.00111	0.00151	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—LHB—polycystic ovary syndrome	0.0011	0.00151	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.0011	0.0015	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—LHB—polycystic ovary syndrome	0.0011	0.0015	CbGpPWpGaD
Conivaptan—AVPR2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.00109	0.00149	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.00109	0.00149	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.00109	0.00148	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.00108	0.00148	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.00108	0.00147	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.00108	0.00147	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.00107	0.00146	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—SCT—polycystic ovary syndrome	0.00103	0.00141	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—SCT—polycystic ovary syndrome	0.00103	0.0014	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.00102	0.0014	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.00102	0.0014	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.00102	0.00139	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.00102	0.00139	CbGpPWpGaD
Conivaptan—AVPR2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000998	0.00136	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000986	0.00135	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000979	0.00134	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000963	0.00132	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000958	0.00131	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000957	0.00131	CbGpPWpGaD
Conivaptan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000952	0.0013	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000951	0.0013	CbGpPWpGaD
Conivaptan—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000939	0.00128	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.00093	0.00127	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000923	0.00126	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000904	0.00123	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000898	0.00123	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000891	0.00122	CbGpPWpGaD
Conivaptan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000885	0.00121	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000881	0.0012	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000875	0.00119	CbGpPWpGaD
Conivaptan—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000873	0.00119	CbGpPWpGaD
Conivaptan—CYP3A4—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.000866	0.00118	CbGpPWpGaD
Conivaptan—AVPR2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000837	0.00114	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000823	0.00112	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000817	0.00112	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000802	0.0011	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000796	0.00109	CbGpPWpGaD
Conivaptan—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000772	0.00105	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000749	0.00102	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000744	0.00102	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000734	0.001	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000729	0.000995	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000728	0.000994	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000723	0.000987	CbGpPWpGaD
Conivaptan—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000717	0.000979	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000705	0.000962	CbGpPWpGaD
Conivaptan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.0007	0.000956	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000699	0.000955	CbGpPWpGaD
Conivaptan—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000698	0.000953	CbGpPWpGaD
Conivaptan—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000691	0.000943	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000685	0.000936	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.00068	0.000929	CbGpPWpGaD
Conivaptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000672	0.000918	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—FST—polycystic ovary syndrome	0.000668	0.000912	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000664	0.000907	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—FST—polycystic ovary syndrome	0.000663	0.000905	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.00066	0.000901	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000659	0.0009	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000655	0.000894	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—LHB—polycystic ovary syndrome	0.000652	0.00089	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—LHB—polycystic ovary syndrome	0.000647	0.000884	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000637	0.00087	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000633	0.000864	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000617	0.000842	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000616	0.000841	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000613	0.000836	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000611	0.000835	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—SCT—polycystic ovary syndrome	0.000611	0.000834	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—SCT—polycystic ovary syndrome	0.000606	0.000828	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000603	0.000823	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000599	0.000817	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000583	0.000796	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000579	0.00079	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000573	0.000782	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000569	0.000776	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000568	0.000775	CbGpPWpGaD
Conivaptan—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000568	0.000775	CbGpPWpGaD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000565	0.000772	CbGpPWpGaD
Conivaptan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000564	0.000771	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000564	0.00077	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000559	0.000763	CbGpPWpGaD
Conivaptan—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000557	0.00076	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000555	0.000758	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—YAP1—polycystic ovary syndrome	0.00053	0.000724	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000526	0.000719	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000523	0.000714	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000519	0.000709	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—INSR—polycystic ovary syndrome	0.0005	0.000683	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—INSR—polycystic ovary syndrome	0.000496	0.000678	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000496	0.000677	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000475	0.000649	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000472	0.000644	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000468	0.000638	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000464	0.000634	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PGR—polycystic ovary syndrome	0.000463	0.000632	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000463	0.000632	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PGR—polycystic ovary syndrome	0.00046	0.000627	CbGpPWpGaD
Conivaptan—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000458	0.000625	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000456	0.000623	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—GHRL—polycystic ovary syndrome	0.00043	0.000588	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PLAT—polycystic ovary syndrome	0.00043	0.000588	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000427	0.000583	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000427	0.000583	CbGpPWpGaD
Conivaptan—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000421	0.000575	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000415	0.000566	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000412	0.000562	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000411	0.00056	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.00041	0.00056	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000408	0.000556	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000404	0.000552	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.0004	0.000547	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000399	0.000544	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000397	0.000543	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000396	0.00054	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000382	0.000521	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000381	0.00052	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000379	0.000517	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000376	0.000514	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000376	0.000514	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000376	0.000513	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PRL—polycystic ovary syndrome	0.000376	0.000513	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000374	0.00051	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PRL—polycystic ovary syndrome	0.000373	0.000509	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000362	0.000494	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000359	0.000491	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000356	0.000486	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000354	0.000483	CbGpPWpGaD
Conivaptan—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000341	0.000466	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—GNAS—polycystic ovary syndrome	0.00033	0.000451	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000328	0.000448	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000315	0.00043	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000312	0.000427	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000309	0.000422	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000307	0.000419	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000302	0.000412	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000297	0.000406	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000265	0.000361	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000263	0.000359	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—LEP—polycystic ovary syndrome	0.000259	0.000353	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—LEP—polycystic ovary syndrome	0.000257	0.000351	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000243	0.000332	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.00024	0.000327	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000231	0.000315	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000229	0.000313	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—POMC—polycystic ovary syndrome	0.000222	0.000304	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—INS—polycystic ovary syndrome	0.000221	0.000302	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—POMC—polycystic ovary syndrome	0.000221	0.000301	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—INS—polycystic ovary syndrome	0.00022	0.0003	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000214	0.000292	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000214	0.000292	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000214	0.000292	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000212	0.00029	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000212	0.00029	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000203	0.000277	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000202	0.000275	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.000196	0.000267	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000196	0.000267	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000182	0.000248	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000181	0.000247	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000164	0.000223	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000162	0.000222	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.000155	0.000211	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.000155	0.000211	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.00014	0.000191	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000139	0.000189	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	0.00013	0.000177	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	0.000123	0.000168	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	0.000117	0.00016	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	0.000104	0.000143	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	9.96e-05	0.000136	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—IL6—polycystic ovary syndrome	9.66e-05	0.000132	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—IL6—polycystic ovary syndrome	9.6e-05	0.000131	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	9.08e-05	0.000124	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	8.88e-05	0.000121	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	8.6e-05	0.000117	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	7.91e-05	0.000108	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	7.66e-05	0.000105	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	7.39e-05	0.000101	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	7.1e-05	9.69e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	7.01e-05	9.57e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	6.62e-05	9.04e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	6.52e-05	8.9e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—TH—polycystic ovary syndrome	5.64e-05	7.7e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	5.48e-05	7.49e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	5.16e-05	7.04e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	4.6e-05	6.28e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	4.38e-05	5.99e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	4.16e-05	5.67e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	3.88e-05	5.29e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	3.14e-05	4.29e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	3.1e-05	4.23e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—INS—polycystic ovary syndrome	3.08e-05	4.21e-05	CbGpPWpGaD
